Resistance to apoptosis is a major obstacle preventing effective therapy for malignancy. Mitochondria localized anti-death proteins of the Bcl-2 family play a central role in inhibiting apoptosis and therefore present valid targets for novel therapy. The peripheral benzodiazepine receptor (PBR) shares a close physical association with the permeability transition pore complex (PTPC), a pivotal regulator of cell death located at mitochondrial contact sites. In this study we investigated the cytotoxicity of the PBR ligand, PK11195, in the micromolar concentration range. PK11195 induced antioxidant inhibitable collapse of the inner mitochondrial membrane potential (∆Ψ m ) and mitochondrial swelling in HL60 human leukaemia cells, but not in SUDHL4 lymphoma cells (which exhibited a higher level of reduced glutathione and relative tolerance to chemotherapy or pro-oxidant induced ∆Ψ m dissipation). PK11195 induced the production of hydrogen peroxide that was not inhibited by Bcl-2 transfection, nor depletion of mitochondrial DNA. ROS production was however blocked by protonophore, implicating a requirement for ∆Ψ m . Our findings suggest that PK11195-induced cytotoxicity relies upon Bcl-2 resistant generation of oxidative stress; a process only observed at concentrations several orders of magnitude higher that required to saturate its receptor. 1397-1404 © 2001 Cancer Research Campaign doi: 10.1054/ bjoc.2001.1788, available online at http://www.idealibrary.com on http://www.bjcancer.com methyl-N-methyl-N-(1-methylpropyl)-isoquinoline carboxamide (PK11195), carbonylcyanide m-chlorophenylhdrazone (CCCP), propidium iodide and all cell culture reagents were purchased from Sigma-Aldrich Ltd, UK. FITC-conjugated mouse antihuman Bcl-2 monoclonal antibody, and the Dako intrastain fixation/permeabilization kit were purchased from Dako, UK.
The peripheral benzodiazepine receptor (PBR) is an 18 000 Dalton transmembrane spanning protein (Joseph Liauzun et al, 1997) distinct from the central benzodiazepine receptor (Braestrup and Squires, 1977) , that localizes to the outer mitochondrial membrane where it shares a close physical association with the voltagedependent anion channel and adenine nucleotide translocator, constituents of the permeability transition pore complex (PTPC) (Anholt et al, 1986; McEnery et al, 1992) . This multimeric structure mediates Ca 2+ and oxidative stress-inducible collapse of the inner mitochondrial membrane potential (∆Ψ m ) by forming a large non-specific megachannel with a size cutoff of around 1500 Daltons (Haworth and Hunter, 1979; Petronilli et al, 1994) . Tremendous growth in interest in the physiology of the PTPC has arisen recently through its involvement in the regulation of both apoptotic and necrotic cell death, processes which involve early ∆Ψ m dissipation (Lemasters et al, 1998) . Furthermore, Bcl-2-related death agonist proteins (e.g. Bax, Bak) and antagonist proteins (e.g. Bcl-2, Bcl-X L ) have been shown to mediate their reciprocal regulatory actions on cell death directly via an interaction with the PTPC at the outer mitochondrial membrane (Narita et al, 1998; Shimizu et al, 1999) .
The PBR specifically binds the compound 1-(2-chlorophenyl)-N-methyl-N-methyl-N-(1-methyl-propyl)-3 isoquinoline-carboxamide (PK11195), with nanomolar affinity. This ligand effects a diverse range of physiological actions including inhibition of cell proliferation and respiratory control (Hirsch et al, 1989; Camins et al, 1995b) , effects on mitochondrial protein and cholesterol translocation Wright and Reichenbecher, 1999) , induction of cell differentiation (Landau et al, 1998) , heat shock protein expression (Camins et al, 1995a) , and facilitation of a diverse range of apoptotic stimuli (Pastorino et al, 1996; Hirsch et al, 1998; Verma et al, 1998) . Consequently, a clearly defined physiological role for the PBR has remained elusive. PK11195 has been shown to reverse the chemoprotective effects of Bcl-2; an effect implicating PBR-mediated antagonism of Bcl-2, and promotion of megachannel formation by the PTPC . However, evidence from independent groups has suggested that the anti-proliferative and respiratory inhibiting effects of PK11195 are receptor-independent (Gorman et al, 1989; Camins et al, 1995b; Zisterer et al, 1998) . Furthermore, the reported pro-apoptotic actions of PK11195 require concentrations several orders of magnitude higher than the reported nanomolar K D for the PBR (Le Fur et al, 1983) . In this study, we have set out to investigate the cytotoxic effects of PK11195. Our findings suggest an important role for PK11195-induced oxidative stress in mediating cytotoxicity, and are consistent with a PBR independent mechanism of action.
MATERIALS AND METHODS

Reagents
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolocarbocyanine iodide (JC-1), 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CMH 2 DCFDA), 5-chloromethylfluorescein diacetate (5-CMFDA), nonyl acridine orange, and 3-3′-dihexyloxacarbocyanine iodide (DiOC 6 (3)) were purchased from Molecular Probes/Cambridge Bioscience, UK. N-acetylcysteine, VP16, ara-C, 5 N,N-dimethylamide (diamide), 1-(2-chlorophenyl)-N-methyl-N-methyl-N-(1-methylpropyl)-isoquinoline carboxamide (PK11195), carbonylcyanide m-chlorophenylhdrazone (CCCP), propidium iodide and all cell culture reagents were purchased from Sigma-Aldrich Ltd, UK. FITC-conjugated mouse antihuman Bcl-2 monoclonal antibody, and the Dako intrastain fixation/permeabilization kit were purchased from Dako, UK.
Cell culture and treatments
HL60, KG1A, K652 cells stably transfected with the Bcl-2 gene (K562 B4) or vector only (K562 N2) (kindly provided by Dr DE Banker and Dr F Applebaum, The Fred Hutchinson Cancer Research Center, USA), and SUDHL4 lymphoma cell lines, were maintained in exponential suspension cultures in RPMI 1640 medium supplemented with 10% fetal calf serum, 5 mM glutamine, 100 µg ml -1 streptomycin and 100 U ml -1 penicillin. Cells were grown in a humidified atmosphere of 5% CO 2 /95% air at 37˚C. PK11195 was dissolved in ethanol at a stock concentration of 8.7 mg ml -1 , and added to cells at a 75 µM final concentration for 4 hours; vehicle alone was also used in medium. To test the effect of an antioxidant on PK11195 activity, cells were treated with 10 mM N-acetylcysteine for 45 minutes prior to treatment with PK11195.
Cells were incubated with VP16, or ara-C at 10 µM final concentration for 24 hours, or with the thiol crosslinking prooxidant, diamide, at 100 µM concentration for 24 hours. The protonophore CCCP was used to dissipate ∆Ψ m by treating cells at a concentration of 10 µM for 15 minutes prior to treatment with PK11195.
Depletion of mitochondrial DNA
KG1A cells were depleted of mitochondrial DNA by culturing for 4 months in medium supplemented with ethidium bromide (400 ng ml -1 ), uridine (5 µg ml -1 ), and glucose (4.5 mg ml -1 ). Loss of mitochondrial DNA was confirmed by 15 cycles of PCR, amplifying a 1023 base pair fragment from the D loop region (upstream primer 5′ CAC CAT TAG CAC CCA AAG CT 3′, reverse primer 5′ CTG TTA AAA GTG CAT ACC GCC A 3′). Semi-quantitative PCR was performed on equal concentrations and serial dilutions of ρ 0 and ρ + DNA, and normalized against nuclear DNA.
Mitochondrial isolation
Cells were homogenized mechanically in buffer A (250 mM sucrose, 10 mM tris, and 1 mM EGTA, pH 7.8 at 4˚C), and the homogenate centrifuged at 600 g for 10 minutes to remove membranes and nuclei. This was followed by a second spin at 15 000 g for 5 minutes in buffer B (250 mM sucrose, 10 mM tris) to obtain a mitochondrial pellet. Analysis at single mitochondrial resolution was performed by flow cytometry using a FACScan (Becton Dickinson, UK), running cellquest software; 30 000 events were aquired in listmode and the mitochondrial population isolated for analysis using a forward versus orthogonal light scatter gate.
Measurement of ∆Ψ m and mitochondrial mass at single cell resolution
Cells were labelled with 5 µg ml -1 of the delocalized lipophilic cation JC-1 for 10 minutes at 37˚C in the dark, prior to analysis by flow cytometry. In the presence of a negative membrane potential, JC-1 forms aggregates which fluoresce in the orange wavelength to provide a measure of ∆Ψ m , whereas the monomeric form fluoresces in the green wavelength providing a measure of mitochondrial mass. The FL-1 (green) and FL-2 (orange) fluorescence signals corresponding to the forward and orthogonal scatter gate circumscribing 10 000 cells were acquired with logarithmic amplification. To determine the proportion of cells with intact plasma membrane undergoing ∆Ψ m in response to chemotherapy and diamide, cells were incubated for 20 minutes at 37˚C in the dark with DiOC 6 (3) (80 nM), then counter stained for 10 minutes with propidium iodide (20 µg ml -1 ). Events with increased PI fluorescence (FL3, red) were removed by gating from the DiOC 6 (3) histograms (FL1) to eliminate dead cells.
Measurement of hydrogen peroxide generation and reduced glutathione
Cells were loaded for 15 minutes at 37˚C in the dark with CMH 2 DCFDA (5 µM) prior to treatment with PK11195, and washed once prior to analysis by flow cytometry using the FL1 fluorescence detector. Cellular reduced glutathione (GSH) was estimated by loading cells with 1 µM 5-CMFDA for 45 minutes at 37˚C in the dark. This probe bonds covalently with intracellular sulfhydryl groups (predominantly GSH) and is then deacetylated to yield the fluorescent product 5-CMF. Cells were washed once prior to flow cytometry and 5-CMF fluorescence was detected in the FL1 wavelength.
Flow cytometric estimation of Bcl-2 oncoprotein expression
Cells (10 6 ) were pelleted and fixed for 15 minutes in the dark using the Dako intrastain solution A (100 µl). The fixed cells were then simultaneously permeabilized and labelled with 1 µg of FITC labelled Bcl-2 antibody for 15 minutes in Dako intrastain solution B. Cells were washed, and analysed using the FL1 detector.
Statistics
Unpaired Student's t-test was used to evaluate the statistical differences between experiments repeated in triplicate. P values shown are two-sided.
RESULTS
PK11195 mediates anti-oxidant inhibitable ∆Ψ m collapse in HL60 cells but not SUDHL4 cells
The effect of PK11195 on ∆Ψ m was investigated in a range of cell lines using the mitochondrial potentiometric probe JC-1 (Reers et al, 1995) . HL60 leukaemia cells treated with PK11195 exhibited a reduction in JC-1 aggregate fluorescence consistent with a collapse in ∆Ψ m ( Figures 1A and 1B) . Pre-treatment of HL60 cells with 10 mM N-acetylcysteine, a sulfhydryl donor and antioxidant, prevented the collapse in ∆Ψ m mediated by PK11195 ( Figure 1C ). PK11195 failed to dissipate ∆Ψ m in the Bcl-2 hyperexpressing SUDHL4 lymphoma cell line, but rather, consistently mediated an increase in JC-1 green fluorescence resulting in the appearance of a second, discrete population of cells with decreased JC-1 orange:JC-1 green fluorescence ratio ( Figures 1D and 1E ).
Changes in JC-1 fluorescence in SUDHL4 cells were temporally associated with an increase in the intensity of mitochondrial cardiolipin labelling by nonyl-acridine orange. The appearance of the PK11195-induced SUDHL4 cell population exhibiting an increase in JC-1 green fluorescence was inhibited by 10 mM N-acetylcysteine ( Figure 1F ).
The differential sensitivity of HL60 versus SUDHL4 cells to PK11195 induced ∆Ψ m collapse was also reflected in the differential tolerance of these cell lines to mitochondrial depolarization induced by cytotoxic chemotherapy and the pro-oxidant diamide, as measured by the potentiometric probe DiOC 6 (3). Treatment with 10 µM Ara-C or 10 µM VP16 mediated ∆Ψ m collapse in a greater fraction of HL60 cells compared with SUDHL4 cells ( Figure 2A) ; this order of differential sensitivity was also observed after treatment with 100 µM diamide (Figure 2A ).
PK11195 induces generation of reactive oxygen species independently of a functional respiratory chain
To investigate the differential effects of PK11195 on HL60 and SUDHL4 cells, the production of reactive oxygen species (ROS) was measured at single cell resolution using the fluorescent probe CMH 2 DCFDA which covalently bonds to intracellular sulfhydryl groups during loading, and is de-acetylated by hydrogen peroxide to generate the fluorescent product CMH 2 DCF. Following treatment with PK11195, an increase in green fluorescence of greater than one log, was observed in both cell lines (Figure 2B and 2C) .
To investigate the role of the respiratory chain in mediating the production of ROS, KG1A leukaemia cells were depleted of their mitochondrial DNA (KG1A ρ 0 ) by long-term culture in the presence of ethidium bromide ( Figure 2D ). Both ρ + and ρ 0 KG1A cells responded to treatment with PK11195 by increasing CMH 2 DCF fluorescence ( Figures 2E and 2F ).
Bcl-2 expression does not prevent PK11195-induced ROS generation
To determine the effect of Bcl-2 on PK11195-induced production of ROS, K562 myeloid leukaemia cells transfected with the Bcl-2 gene ( Figure 3A) were treated with PK11195 after loading with CMH 2 DCFDA. Bcl-2 expression, shown by immunofluorescence to be predominantly mitochondrial, (Dr Deborah Banker, personal communication), did not affect the PK11195-induced increase in CMH 2 DCF fluorescence, which was equivalent in K562 N2 and K562 B4 cell lines ( Figures 3B and 3C ). The differential effects of the pro-oxidant diamide on HL60 and SUDHL4 cells, and the reversibility of PK11195 induced ∆Ψ m collapse in HL60 cells by antioxidant, suggested that the underlying sensitivity of these contrasting cell lines may result from intrinsic differences in their oxidant stress buffering capacities. Using the sulfhydryl-reactive fluorescent probe 5-CMFDA to estimate reduced glutathione (GSH) at single cell resolution, Bcl-2 transfection was found not to produce a change in 5-CMF fluorescence ( Figure 3D ). However, SUDHL4 cells exhibited greater 5-CMF fluorescence compared with HL60 cells ( Figure 3E ).
Mitochondrial toxicity mediated by PK11195 requires mitochondrial energization
To examine the pro-oxidant effects of PK11195 at the sub-cellular level, mitochondria were isolated from HL60 and SUDHL4 cells after treatment with PK11195. HL60 mitochondria consistently increased the median of their forward light scatter distribution by approximately one log compared with control, consistent with an increase in mitochondrial size occurring at a time coincident with ROS generation ( Figure 3F ). However, an increase in forward scatter was not observed in SUDHL4 mitochondria after 4 hours of incubation (not shown).
Production of ROS by PK11195 was found to be restricted to cells with normal (non-apoptotic) morphology, reflected in the forward and side light scatter distributions (FSC and SSC respectively). Cells undergoing apoptosis exhibit an increase in SSC (reflecting an increased granularity), and a reduction in FSC (reflecting a reduction in cell size); we have previously observed an association with ∆Ψ m collapse in this low FSC/high SSC population (Fennell and Cotter, 2000) . HL60 cells treated with PK11195 exhibited an increase in apoptotic (low FSC/high SSC) frequency associated with a reduction in membrane potential ( Figure 4A) , that was not seen in SUDHL4 cells. When the apoptotic and normal cells were gated (using the regions denoted R1 and R2 respectively), ROS production was only observed in the morphologically normal cells ( Figure 4B ). This observation suggested a requirement for mitochondrial energization in the generation of ROS by PK11195. To test this hypothesis, HL60 cells were treated with the protonophore CCCP to collapse ∆Ψ m prior to treatment with PK11195 ( Figure 4C ). In the presence of CCCP, PK11195 failed to increase CMH 2 DCF fluorescence compared with control, in contrast to cells treated with PK11195 in the absence of the protonophore (Figures 4D and 4E ).
DISCUSSION
In this study, we have investigated the cytotoxicity of the PBR ligand PK11195 in a range of haemopoetic cell lines. The relative susceptibility of HL60 cells versus SUDHL4 cells to mitochondrial depolarization induced by PK11195, chemotherapeutic drugs and the pro-oxidant diamide suggests a role for intrinsic anti-oxidant defences in modulating the toxicity of PK11195. This was supported by the observation that exogenous antioxidant treatment protects HL60 cells from PK11195 induced mitochondrial toxicity, consistent with an involvement of ROS in mediating ∆Ψ m collapse. The ability of PK11195 to induce ROS generation in the presence of sustained ∆Ψ m in SUDHL4 cells implies that ∆Ψ m collapse is not a prerequisite for ROS generation, in contrast to the paradigm described by Zamzami et al in relation to several other apoptosis-inducing toxins (Zamzami et al, 1995) . SUDHL4 cells exhibited a relatively higher GSH concentration compared with HL60 cells and could account for the greater intensity of PK11195-induced CMH 2 DCF fluorescence in HL60 cells (approximately one log fold). Bcl-2 transfection was not found to attenuate the generation of ROS in K562 cells, nor modulate cellular GSH content; however, Bcl-2 could conceivably antagonize ROS-induced permeability transition via its well described stabilizing effect on the permeability transition pore complex, the gating of which is regulated by the redox state of critical vicinal thiols (Costantini et al, 1996 (Costantini et al, , 2000 Marzo et al, 1998) . This would be consistent with our finding that PK11195 can induce mitochondrial swelling in HL60 mitochondria, but not in SUDHL4 mitochondria which hyperexpress Bcl-2 due to t(14;18).
The increase in JC-1 monomer fluorescence that we observed in PK11195 treated SUDHL4 cells has been previously reported to occur as an early event during some forms of apoptosis, and has been shown to reflect mitochondrial proliferation using corroborative transmission electron microscopy (TEM) (Mancini et al, 1997 (Mancini et al, , 1998 . The observed increase in cardiolipin labelling of SUDHL4 cells by nonyl-acridine orange has also been reported by Miccoli et al to occur in PK11195-treated human glioma cells, consistent with an increase in mitochondrial mass (Miccoli et al, 1999 ). Becker's group reported PK11195-induced mitochondrial proliferation using TEM in rat C6 glioma cells and pituitary GH 3 cells (Shiraishi et al, 1991; Black et al, 1994) , however, the basis for this proliferation was not investigated. Transcription of nuclear mitochondrial biogenesis genes is induced by oxidative stress (Miranda et al, 1999) , consistent with observations by us and by Camins et al (Camins et al, 1995a ) that PK11195 induces ROS, and may therefore underlie the antioxidant reversible increase in JC-1 green and NAO fluorescence.
PK11195 facilitated mitochondrial permeability transition induced by a diversity of apoptosis inducers has been previously reported (Pastorino et al, 1994 (Pastorino et al, , 1996 Hirsch et al, 1998) , as well as direct induction of ∆Ψ m dissipation in thymocytes (Tanimoto et al, 1999) . The requirement for micromolar concentrations of PK11195 to achieve the effects described in this study suggests a mechanism of toxicity that is independent of the PBR, since the equilibrium-binding constant is only 1 nM (Le Fur et al, 1983) . Carayon et al showed that PBR transfection could protect Jurkat leukaemia cells from ROS induced cytotoxicity (Carayon et al, 1996) . However, we have observed that SUDHL4 and BV173 cells exhibit comparable PBR expression, (measured using 7-nitro-2,1,3-benzoxadiazol-4-y1 derivative of 2-phenylindole-3-acetamide (NBD FGIN-1-27 analogue), a fluorescent PBR probe (Kozikowski et al, 1997) ), yet exhibit differential tolerance to the effects of PK11195 on ∆Ψ m ; furthermore, Jurkat T cells which lack demonstrable NBD FGIN-1-27 binding, dramatically produce ROS in response to PK11195 (unpublished data). The origin of PK11195 induced ROS is unknown. CMH 2 DCFDA is oxidized to CMH 2 DCF by H 2 O 2 , which is generated intracellularly by dismutation of superoxide catalysed by manganese superoxide dismutase (MnSOD). The principal mitochondrial defence against H 2 O 2 is the glutathione redox cycle system which converts H 2 O 2 to H 2 O at the expense of GSH oxidation to its disulfide, GSSG, by the action of glutathione peroxidase. The relatively lower 5-CMF fluorescence of HL60 cells, is consistent with a lower total cellular GSH level, which could increase susceptibility to oxidation of the mitochondrial GSH pool by PK11195 compared with SUDHL4 cells. Disruption of mitochondrial H 2 O 2 defences allows the generation of hydroxyl radical via contact with transition metal ions (Cu + or Fe 2+ ) with the potential to trigger permeability transition. The chloromethyl function of CMH 2 DCFDA is thiol reactive, however, GSH is present in the millimolar range (some 3 orders of magnitude greater than the concentration of CMH 2 DCFDA), arguing on stoichiometric grounds, against an artefactual pertubation in intracellular GSH levels as a basis for PK11195-mediated ROS.
Generation of H 2 O 2 in KG1A ρ 0 cells suggests that a functional respiratory chain is not required for PK11195-induced ROS. However, we have shown in this study that ∆Ψ m (maintained in ρ 0 cells by reverse proton flux through complex V) is a pre-requisite for ROS production. PK11195 may therefore require ∆Ψ mdependent entry into the mitochondrial matrix in a manner resembling the isoquinoline derivative N-methyl 4-phenyl pyridine, which occurs after protonation of 1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP) (Ramsay et al, 1986) ; experiments to test this electrophoretic import hypothesis are currently under investigation. The reported Bcl-2 reversing efficacy of PK11195 suggests that this compound may possess useful apoptosissensitizing efficacy, with potential application for the therapy of apoptosis-resistant malignancies . Further investigations to unravel underlying mechanisms of its pro-apop- Events totic activity should help to separate PBR versus PBR liganddependent processes, and in so doing, clarify the biological role of this elusive receptor.
